Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Self-controlled Clinical Trial to Validate Optical Ultrasonic Flow Ratio (OUFR) Based on Intravascular Imaging

NCT06726252 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.

NCT NCT06726252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06726252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Self-controlled Clinical Trial to Validate Optical Ultrasonic Flow Ratio (OUFR) Based on Intravascular Imaging
Lead sponsor
Harbin Medical University
Phase
Not applicable
Overall status
Completed
Start date
November 10, 2024
Completion date
June 30, 2025
Enrollment
114 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, fractional flow reserve